A detailed history of Commerzbank Aktiengesellschaft transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Commerzbank Aktiengesellschaft holds 402 shares of REGN stock, worth $331,440. This represents 0.01% of its overall portfolio holdings.

Number of Shares
402
Previous 231 74.03%
Holding current value
$331,440
Previous $243,000 74.07%
% of portfolio
0.01%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$1024.09 - $1201.76 $175,119 - $205,500
171 Added 74.03%
402 $423,000
Q2 2024

Jul 22, 2024

BUY
$883.2 - $1071.19 $204,019 - $247,444
231 New
231 $243,000
Q2 2020

Jul 21, 2020

SELL
$493.32 - $643.92 $3.1 Million - $4.05 Million
-6,287 Closed
0 $0
Q1 2020

Oct 03, 2024

BUY
$336.18 - $494.43 $2.04 Million - $2.99 Million
6,056 Added 2621.65%
6,287 $3.07 Million
Q1 2020

Apr 29, 2020

SELL
$336.18 - $494.43 $1.15 Million - $1.7 Million
-3,435 Reduced 35.33%
6,287 $3.07 Million
Q4 2019

Oct 03, 2024

BUY
$274.13 - $376.51 $2.6 Million - $3.57 Million
9,491 Added 4108.66%
9,722 $3.65 Million
Q4 2019

Jan 17, 2020

SELL
$274.13 - $376.51 $5.48 Million - $7.53 Million
-19,989 Reduced 67.28%
9,722 $3.65 Million
Q3 2019

Oct 03, 2024

BUY
$273.46 - $318.39 $8.06 Million - $9.39 Million
29,480 Added 12761.9%
29,711 $8.24 Million
Q3 2019

Oct 17, 2019

BUY
$273.46 - $318.39 $734,240 - $854,877
2,685 Added 9.93%
29,711 $8.24 Million
Q2 2019

Oct 03, 2024

BUY
$299.6 - $414.82 $8.03 Million - $11.1 Million
26,795 Added 11599.57%
27,026 $8.46 Million
Q2 2019

Jul 23, 2019

SELL
$299.6 - $414.82 $1.14 Million - $1.58 Million
-3,808 Reduced 12.35%
27,026 $8.46 Million
Q1 2019

Oct 03, 2024

BUY
$372.08 - $439.57 $11.4 Million - $13.5 Million
30,603 Added 13248.05%
30,834 $12.7 Million
Q1 2019

May 13, 2019

BUY
$372.08 - $439.57 $1.07 Million - $1.27 Million
2,880 Added 10.3%
30,834 $12.7 Million
Q4 2018

Oct 03, 2024

BUY
$335.82 - $403.04 $9.31 Million - $11.2 Million
27,723 Added 12001.3%
27,954 $10.4 Million
Q4 2018

Feb 06, 2019

BUY
$335.82 - $403.04 $134,328 - $161,216
400 Added 1.45%
27,954 $10.4 Million
Q3 2018

Oct 04, 2024

BUY
$351.14 - $408.51 $9.59 Million - $11.2 Million
27,323 Added 11828.14%
27,554 $11.1 Million
Q3 2018

Nov 13, 2018

BUY
$351.14 - $408.51 $4.14 Million - $4.81 Million
11,776 Added 74.64%
27,554 $11.1 Million
Q2 2018

Oct 04, 2024

BUY
$284.6 - $344.99 $4.42 Million - $5.36 Million
15,547 Added 6730.3%
15,778 $5.44 Million
Q2 2018

Aug 10, 2018

SELL
$284.6 - $344.99 $6.79 Million - $8.24 Million
-23,873 Reduced 60.21%
15,778 $5.44 Million
Q1 2018

Oct 04, 2024

BUY
$315.82 - $393.78 $1.06 Million - $1.32 Million
3,363 Added 9.27%
39,651 $13.7 Million
Q1 2018

May 01, 2018

BUY
$315.82 - $393.78 $1.06 Million - $1.32 Million
3,363 Added 9.27%
39,651 $13.7 Million
Q4 2017

Oct 04, 2024

BUY
$358.63 - $469.95 $12.9 Million - $16.9 Million
36,057 Added 15609.09%
36,288 $13.6 Million
Q4 2017

Jan 26, 2018

SELL
$358.63 - $469.95 $2.03 Million - $2.66 Million
-5,656 Reduced 13.48%
36,288 $13.6 Million
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $6.64 Million - $7.76 Million
15,395 Added 57.99%
41,944 $18.8 Million
Q2 2017

Aug 09, 2017

BUY
N/A
26,549
26,549 $13 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $88.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Commerzbank Aktiengesellschaft Portfolio

Follow Commerzbank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.